Astal Laboratories Intrinsic Value
Astal Laboratories (ASTALLTD) median intrinsic value is ₹77.86 from 8 valuation models (range ₹52–₹120), vs current price ₹82.26 — -5.3% downside (Trading Near Calculated Value), margin of safety -5.7%. Compare with ASTALLTD fair value to assess whether the stock is under or overvalued.
ASTALLTD Valuation Methods Summary — DCF, Graham Number & P/E
Astal Laboratories intrinsic value across 8 models vs current price ₹82.26 — upside/downside and value range per method. Read ASTALLTD dividend track record for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹97.92 | ₹78.34 - ₹117.50 | +19.0% | EPS: ₹8.16, Sector P/E: 12x |
| Book Value Method | asset | ₹77.86 | ₹70.07 - ₹85.65 | -5.3% | Book Value/Share: ₹77.86, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹102.10 | ₹91.89 - ₹112.31 | +24.1% | Revenue/Share: ₹127.62, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹57.14 | ₹51.43 - ₹62.85 | -30.5% | EBITDA: ₹40.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹52.22 | ₹47.00 - ₹57.44 | -36.5% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹67.24 | ₹60.52 - ₹73.96 | -18.3% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹76.19 | ₹68.57 - ₹83.81 | -7.4% | ROE: 9.8%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹119.56 | ₹107.60 - ₹131.52 | +45.3% | EPS: ₹8.16, BVPS: ₹77.86 |
ASTALLTD Intrinsic Value vs Market Price — All Valuation Models
Astal Laboratories fair value range ₹52–₹120 vs current market price ₹82.26 across 8 valuation models. For current market price and key ratios, visit Astal Laboratories share price today.
ASTALLTD Intrinsic Value Analysis — Undervalued or Overvalued?
Astal Laboratories median intrinsic value ₹77.86, current price ₹82.26 — Trading Near Calculated Value by 5.3%, margin of safety -5.7%.
What is the intrinsic value of ASTALLTD?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Astal Laboratories (ASTALLTD) is ₹77.86 (median value). With the current market price of ₹82.26, this represents a -5.3% variance from our estimated fair value.
The valuation range spans from ₹52.22 to ₹119.56, indicating ₹52.22 - ₹119.56.
Is ASTALLTD undervalued or overvalued?
Based on our multi-method analysis, Astal Laboratories (ASTALLTD) appears to be trading near calculated value by approximately 5.3%.
ASTALLTD Financial Health — Key Ratios vs Industry Benchmarks
Astal Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 103.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 9.8% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 8.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.34x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
ASTALLTD Cash Flow Quality — Operating & Free Cash Flow
Astal Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-13 Cr | ₹-17 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-6 Cr | ₹-9 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |